All lobbying filings

THE GIBSON GROUP, LLC

Lobbying for ASSOCIATION FOR ACCESSIBLE MEDICINES · National trade organization representing the interests of generic drug manufacturers.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 16, 2026

Official filing document

Bills named in this filing 3

S 1096
Preserve Access to Affordable Generics and Biosimilars Act
S 1041
Affordable Prescriptions for Patients Act
S 1040
Drug Competition Enhancement Act

Lobbying activity 4

Health Issues

Drug competition issues Monitor drug supply chain issues

Labor Issues/Antitrust/Workplace

Drug competition issues

Monitor S. 1096 - patent settlements Issues relating to review of pharmaceutical patents in inter partes reviews Issues relating to the Patent Trial and Appeal Board Patent thickets - S. 1041 Monitor S. 1040 - product hopping Skinny labeling issues Monitor issues relating to the Patent Eligibility Restoration Act Monitor issues relating to the PREVAIL Act

Trade (domestic/foreign)

Monitor issues related to trade agreeements

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.